Advanced Fat Loss Stack
Triple agonist + GLP-1 combination
Why This Stack Works
Retatrutide provides triple GLP-1/GIP/glucagon receptor agonism for maximum metabolic effect. Semaglutide adds complementary GLP-1 pathway support for appetite regulation.
This combination draws from Metabolic research, targeting metabolic, weight loss, GLP-1, retatrutide, semaglutide. The compounds in this stack act on distinct receptor systems and biological pathways, making them suitable for combined use without mechanism overlap.
All compounds in this stack are supplied by Apollo Peptide Sciences with independent third-party Certificate of Analysis (COA) documentation confirming 99%+ purity. They are sold strictly for laboratory and educational use only and are not FDA-approved for human therapeutic use.
Research Protocol
Retatrutide: titrate 1–12 mg/week SC. Semaglutide: titrate 0.25–2.4 mg/week SC. Duration: 12–24 weeks with medical supervision in research settings.
Stack Components
GLP-3 R 15mg
MetabolicMid-size retatrutide vial for standard research protocols.
- Triple receptor agonism
- Extended protocol supply
- Advanced metabolic research
GLP-1 S 10mg
MetabolicMid-size semaglutide vial for standard research protocols.
- Extended protocol supply
- GLP-1 receptor agonism
- Appetite and glucose regulation
Frequently Asked Questions
What is the Advanced Fat Loss Stack?
The Advanced Fat Loss Stack is a synergistic research peptide protocol designed for triple agonist + glp-1 combination. Retatrutide provides triple GLP-1/GIP/glucagon receptor agonism for maximum metabolic effect. Semaglutide adds complementary GLP-1 pathway support for appetite regulation.
What is the protocol for the Advanced Fat Loss Stack?
Retatrutide: titrate 1–12 mg/week SC. Semaglutide: titrate 0.25–2.4 mg/week SC. Duration: 12–24 weeks with medical supervision in research settings. Note: All compounds are for research and laboratory use only and are not intended for human therapeutic application. Consult the relevant preclinical literature before designing any research protocol.
What compounds are in the Advanced Fat Loss Stack?
This stack includes GLP-3 R 15mg, GLP-1 S 10mg. Key benefits include: GLP-3 R 15mg: Triple receptor agonism; GLP-1 S 10mg: Extended protocol supply. Each compound targets a distinct mechanism, making them suitable for combined research use without pathway redundancy.
Explore More Stacks
Browse all 9 synergistic peptide protocols or explore the full product catalog.